StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report published on Monday. The firm issued a sell rating on the stock.
Separately, HC Wainwright increased their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
Read Our Latest Stock Report on SenesTech
SenesTech Stock Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- What is Short Interest? How to Use It
- Oracle Announces Game-Changing News for the AI Industry
- Where to Find Earnings Call Transcripts
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.